Literature DB >> 24597893

Redox control of microglial function: molecular mechanisms and functional significance.

Ana I Rojo1, Gethin McBean, Marina Cindric, Javier Egea, Manuela G López, Patricia Rada, Neven Zarkovic, Antonio Cuadrado.   

Abstract

Neurodegenerative diseases are characterized by chronic microglial over-activation and oxidative stress. It is now beginning to be recognized that reactive oxygen species (ROS) produced by either microglia or the surrounding environment not only impact neurons but also modulate microglial activity. In this review, we first analyze the hallmarks of pro-inflammatory and anti-inflammatory phenotypes of microglia and their regulation by ROS. Then, we consider the production of reactive oxygen and nitrogen species by NADPH oxidases and nitric oxide synthases and the new findings that also indicate an essential role of glutathione (γ-glutamyl-l-cysteinylglycine) in redox homeostasis of microglia. The effect of oxidant modification of macromolecules on signaling is analyzed at the level of oxidized lipid by-products and sulfhydryl modification of microglial proteins. Redox signaling has a profound impact on two transcription factors that modulate microglial fate, nuclear factor kappa-light-chain-enhancer of activated B cells, and nuclear factor (erythroid-derived 2)-like 2, master regulators of the pro-inflammatory and antioxidant responses of microglia, respectively. The relevance of these proteins in the modulation of microglial activity and the interplay between them will be evaluated. Finally, the relevance of ROS in altering blood brain barrier permeability is discussed. Recent examples of the importance of these findings in the onset or progression of neurodegenerative diseases are also discussed. This review should provide a profound insight into the role of redox homeostasis in microglial activity and help in the identification of new promising targets to control neuroinflammation through redox control of the brain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24597893      PMCID: PMC4186766          DOI: 10.1089/ars.2013.5745

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  371 in total

1.  Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells.

Authors:  T Koppal; T V Petrova; L J Van Eldik
Journal:  Brain Res       Date:  2000-06-09       Impact factor: 3.252

Review 2.  Microglia and neuroprotection: implications for Alzheimer's disease.

Authors:  Wolfgang J Streit
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

3.  Microglial glutamate uptake is coupled to glutathione synthesis and glutamate release.

Authors:  Mikael Persson; Mats Sandberg; Elisabeth Hansson; Lars Rönnbäck
Journal:  Eur J Neurosci       Date:  2006-08-21       Impact factor: 3.386

4.  Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

Authors:  Juan E Tichauer; Betsi Flores; Bernardita Soler; Laura Eugenín-von Bernhardi; Gigliola Ramírez; Rommy von Bernhardi
Journal:  Brain Behav Immun       Date:  2013-12-29       Impact factor: 7.217

5.  c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.

Authors:  Vicki Waetzig; Karen Czeloth; Ute Hidding; Kirsten Mielke; Moritz Kanzow; Stephan Brecht; Mario Goetz; Ralph Lucius; Thomas Herdegen; Uwe-Karsten Hanisch
Journal:  Glia       Date:  2005-05       Impact factor: 7.452

6.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

Authors:  Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla
Journal:  Brain Res       Date:  2010-03-01       Impact factor: 3.252

Review 7.  Lipid peroxidation and neurodegenerative disease.

Authors:  Tanea T Reed
Journal:  Free Radic Biol Med       Date:  2011-06-30       Impact factor: 7.376

8.  Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Bipanjeet Sekhon; Manu Jatana; Shailendra Giri; Anne G Gilg; Charanpal Sekhon; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

9.  Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases.

Authors:  Avik Roy; Arundhati Jana; Kavitha Yatish; Matthew B Freidt; Yiu K Fung; Jeffrey A Martinson; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2008-06-06       Impact factor: 7.376

10.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

View more
  105 in total

Review 1.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

Review 2.  Microglia antioxidant systems and redox signalling.

Authors:  F Vilhardt; J Haslund-Vinding; V Jaquet; G McBean
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 3.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

Review 4.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

5.  Fractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in Mice.

Authors:  Elisa R Zanier; Federica Marchesi; Fabrizio Ortolano; Carlo Perego; Maedeh Arabian; Tommaso Zoerle; Eliana Sammali; Francesca Pischiutta; Maria-Grazia De Simoni
Journal:  J Neurotrauma       Date:  2015-09-08       Impact factor: 5.269

Review 6.  NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease.

Authors:  J Haslund-Vinding; G McBean; V Jaquet; F Vilhardt
Journal:  Br J Pharmacol       Date:  2016-02-26       Impact factor: 8.739

Review 7.  Redox-based therapeutics in neurodegenerative disease.

Authors:  G J McBean; M G López; F K Wallner
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

8.  Time to get Personal: A Framework for Personalized Targeting of Oxidative Stress in Neurotoxicity and Neurodegenerative Disease.

Authors:  Matthew Neal; Jason R Richardson
Journal:  Curr Opin Toxicol       Date:  2018-02-15

Review 9.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

Review 10.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.